Drug Therapy for Behavioral and Psychological Symptoms of Dementia

Dementia, which can be induced by diverse factors, is a clinical syndrome characterized by the decline of cognitive function. Behavioral and psychological symptoms of dementia (BPSD) include depression, agitation, and aggression. Dementia causes a heavy burden on patients and their caregivers. Patients with BPSD should be assessed comprehensively by practitioners and offered appropriate non-pharmacologic and pharmacologic therapy. Non-pharmacologic therapy has been recommended as the basal treatment for BPSD; however, pharmacologic therapy is required under many situations. Medications, including antipsychotic agents, antidepressants, sedative and hypnotic agents, mood stabilizers, cholinesterase inhibitors, and amantadine, are extensively used in clinical practice. We have reviewed the progression of pharmacologic therapy for BPSD.

• Publication year

  2016

• Venue

  Current Neuropharmacology

• Publication date

  2016-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.2174/1570159X14666151208114232PMID 26644152PMCID 4876586
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Valproate preparations for agitation in dementia.

  2018cited by this paper
• Dementia friendly, dementia capable, and dementia positive: concepts to prepare for the future.

  2015cited by this paper
• Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.

  2014cited by this paper
• [Issues surrounding the treatment of psychological disorders in the elderly].

  2014cited by this paper
• Apathy and Dementia. Nosology, Assessment and Management

  2014cited by this paper
• Current prevalence of dementia, depression and behavioural problems in the older adult care home sector: the South East London Care Home Survey.

  2014cited by this paper
• The value of personalized psychosocial interventions to address behavioral and psychological symptoms in people with dementia living in care home settings: a systematic review

  2014cited by this paper
• Prevalence of anxiety and depression in caregivers of Alzeheimer's dementia patients.

  2014cited by this paper
• Lewy body dementia: the impact on patients and caregivers

  2014cited by this paper
• Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration?

  2014cited by this paper
• [Neurobehavioral manifestation in early period of Alzheimer disease and vascular dementia].

  2014cited by this paper
• Behavioural and Psychological Symptoms in Poststroke Vascular Cognitive Impairment

  2014cited by this paper
• The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis

  2014cited by this paper
• Does the falls efficacy scale international version measure fear of falling: a reassessment of internal validity using a factor analytic approach.

  2014cited by this paper
• From rural to urban areas: differences in behavioural and psychological symptoms of dementia in nursing home residents according to geographical location

  2014cited by this paper
• Efficacy and Tolerability of Benzodiazepines for the Treatment of Behavioral and Psychological Symptoms of Dementia

  2014cited by this paper
• Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease.

  2014cited by this paper
• Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis

  2014cited by this paper
• A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia.

  2014cited by this paper
• Factors associated with increased caregivers' burden in several cognitive stages of Alzheimer's disease

  2014cited by this paper
• The role of therapeutic use of self in the application of nonpharmacological interventions.

  2014cited by this paper
• Emotional function in dementia patients

  2014cited by this paper
• Pharmacological versus non-pharmacological approaches to managing challenging behaviours for people with dementia.

  2014cited by this paper
• Aripiprazole in the treatment of Alzheimer's disease

  2013influential reference
• [Experience of a care pathway for psychological and behavioral symptoms of dementia].

  2013cited by this paper
• Grouping of behavioural and psychological symptoms of dementia

  2013cited by this paper
• [Frontotemporal dementia: clinical features, genetics, pathogenesis and treatment].

  2013cited by this paper
• Adjustment, depression, and anxiety in mild cognitive impairment and early dementia: a systematic review of psychological intervention studies

  2013cited by this paper
• Risk of mortality among individual antipsychotics in patients with dementia.

  2012cited by this paper
• Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial

  2012cited by this paper
• Antidepressants for agitation and psychosis in patients with dementia.

  2012cited by this paper
• Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.

  2012cited by this paper
• Effect of Selective Serotonin Reuptake Inhibitors in Alzheimer’s Disease with Comorbid Depression

  2012cited by this paper
• Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.

  2011cited by this paper
• Practical guidelines for the acute emergency sedation of the severely agitated older patient

  2011cited by this paper
• Neuropsychiatric symptoms in Alzheimer's disease

  2011cited by this paper
• Antidepressants for agitation and psychosis in dementia.

  2011cited by this paper
• Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors

  2009cited by this paper
• The involvement of retinoic acid receptor-alpha in corticotropin-releasing hormone gene expression and affective disorders.

  2009cited by this paper
• Valproate preparations for agitation in dementia.

  2009cited by this paper
• The efficacy of mirtazapine in agitated patients with Alzheimer’s disease: A 12-week open-label pilot study

  2008cited by this paper
• Exposure to antipsychotics and risk of stroke: self controlled case series study

  2008cited by this paper
• Point and 5‐year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study

  2008cited by this paper
• [Anticonvulsant mood stabilizers in the treatment of behavioral and psychological symptoms of dementia (BPSD)].

  2008influential reference
• Pharmacological Treatment of the Psychosis of Alzheimer’s Disease

  2007influential reference
• Donepezil for the treatment of agitation in Alzheimer's disease.

  2007cited by this paper
• A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia.

  2007cited by this paper
• Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study.

  2007cited by this paper
• Antipsychotic Drug Use and Mortality in Older Adults with Dementia

  2007cited by this paper
• Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

  2006influential reference
• Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial.

  2006cited by this paper
• Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.

  2006influential reference
• Neuroleptic drugs in dementia: benefits and harm

  2006cited by this paper
• Memantine for dementia.

  2006cited by this paper
• Prevalence and Predictors of Neuropsychiatric Symptoms in Cognitively Impaired Nursing Home Patients

  2006cited by this paper
• Rates of clinical depression diagnosis, functional impairment, and nursing home placement in coexisting dementia and depression.

  2005cited by this paper
• Memantine for dementia.

  2005cited by this paper
• A randomized, double-blind, placebo-controlled pilot trial of safety and tolerability of two doses of divalproex sodium in outpatients with probable Alzheimer's disease.

  2005cited by this paper
• Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial.

  2005cited by this paper
• Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.

  2005cited by this paper
• Aripiprazole for the Treatment of Psychosis in Patients With Alzheimer's Disease: A Randomized, Placebo-Controlled Study

  2005cited by this paper
• Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

  2004cited by this paper
• Valproate therapy for agitation in dementia: open-label extension of a double-blind trial.

  2003cited by this paper
• The Consequences of Non-Cognitive Symptoms of Dementia in Medical Hospital Departments

  2003cited by this paper
• Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis.

  2003cited by this paper
• Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

  2003cited by this paper
• The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.

  2002influential reference
• Haloperidol for agitation in dementia.

  2002cited by this paper
• Patient and caregiver characteristics and nursing home placement in patients with dementia.

  2002cited by this paper
• Sodium valproate in the treatment of aggressive behavior in patients with dementia—a randomized placebo controlled clinical trial

  2002cited by this paper
• Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients.

  2002cited by this paper
• Antidepressants for treating depression in dementia.

  2002cited by this paper
• A Double-Blind, Placebo-Controlled Study of Fluoxetine in Depressed Patients With Alzheimer's Disease

  2001cited by this paper
• A pilot randomized trial of carbamazepine for behavioral symptoms in treatment-resistant outpatients with Alzheimer disease.

  2001cited by this paper
• Placebo-controlled study of divalproex sodium for agitation in dementia.

  2001cited by this paper
• Introduction: antipsychotic treatment of behavioral and psychological symptoms of dementia in geropsychiatric patients.

  2001cited by this paper
• A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease.

  2000cited by this paper
• Carbamazepine Treatment of Agitation in Nursing Home Patients with Dementia: A Preliminary Study

  1994cited by this paper
• A Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia

  1990cited by this paper
• Multicenter study comparing thioridazine with diazepam and placebo in elderly, nonpsychotic patients with emotional and behavioral disorders.

  1984cited by this paper
• Uber eine eigenartige Erkrankung der Hirnrinde

  year unknowncited by this paper

• Emotionally Personalized Doll Therapy for Behavioral Symptoms in an 88‐Year‐Old Woman With Alzheimer's Disease: A Case Report

  2025cites this paper
• Treatment for Alzheimer's disease.

  2025cites this paper
• Inhibitory Actions of Antidepressants, Hypnotics, and Anxiolytics on Recombinant Human Acetylcholinesterase Activity.

  2024cites this paper
• Current Diagnostic Challenges in Late-Life Depression and Neurocognitive Disorders

  2024cites this paper
• Review of Current Clinical Options for the Management of Behavioral and Psychological Symptoms of Dementia.

  2024cites this paper
• The benefits of caregiver singing and receptive music in dementia care: a qualitative study of professional caregivers’ experiences

  2024cites this paper
• A novel approach towards behavioral and psychological symptoms of dementia management

  2023cites this paper
• Needs Assessment and the Identification of Palliative Care Dimensions of the Essential Service Package for the Elderly with Alzheimer’s Disease: A Mixed Exploratory Study

  2023cites this paper
• Antipsychotic Drug Reduction Through the Implementation of a Neurologically Oriented, Interdisciplinary Psycho-Diagnostic and Antipsychotic Stewardship Program.

  2023cites this paper
• The past and present of therapeutic strategy for Alzheimer’s diseases: potential for stem cell therapy

  2023cites this paper
• Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals

  2022cites this paper
• Caregiver Singing Intervention: Do Expressions of Emotion and Resistance Differ Between Persons with Vascular Dementia and Those with Alzheimer’s Disease? A Pilot Study

  2022cites this paper
• Dementia model mice exhibited improvements of neuropsychiatric symptoms as well as cognitive dysfunction with neural cell transplantation

  2021cites this paper
• The Behavioral Effects of Combination Therapy of Memantine and Acetylcholinesterase Inhibitors Compared with Acetylcholinesterase Inhibitors Alone in Patients with Moderate Alzheimer’s Dementia: A Double-Blind Randomized Placebo-Controlled Trial

  2021cites this paper
• Rationale, Design, and Methodology of a Prospective Cohort Study for Coping with Behavioral and Psychological Symptoms of Dementia: The RECage Project

  2021cites this paper
• Female dominance of both spatial cognitive dysfunction and neuropsychiatric symptoms in a mouse model of Alzheimer’s disease

  2021cites this paper
• The neuro-inammasome in Alzheimer’s disease and cerebral Stroke

  2021cites this paper
• Antidepressants in Alzheimer’s Disease: A Focus on the Role of Mirtazapine

  2021cites this paper
• Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease

  2021cites this paper
• Feasibility of the Cognitive Model for Behavioral Interventions in Older Adults with Behavioral and Psychological Symptoms of Dementia

  2020cites this paper
• Impact of deprescribing AChEIs on aggressive behaviors and antipsychotic prescribing

  2020cites this paper
• Like a bridge over troubled water – a qualitative study of professional caregiver singing and music as a way to enable person-centred care for persons with dementia

  2020cites this paper
• REDUCING AGITATION IN LONG-TERM CARE: A VIRTUAL REALITY INTERVENTION FOR DEMENTIA

  2019cites this paper
• Commentary on "Caregiver-Care Recipient Relationship Closeness is Associated With Neuropsychiatric Symptoms in Dementia".

  2019cites this paper
• Alzheimer's Disease and Other Neurodegenerative Diseases

  2019cites this paper
• The Progression of Dementia and Cognitive Decline in a Dutch 2-Year Cohort Study of People with Young-Onset Dementia

  2018cites this paper
• Use of Antiepileptic Drugs and Dementia Risk—an Analysis of Finnish Health Register and German Health Insurance Data

  2018cites this paper
• Pharmacotherapy for dementia

  2018cites this paper
• Rehabilitation strategy for hip fracture, focused on behavioral psychological symptoms of dementia for older people with cognitive impairment: A nationwide Japan rehabilitation database

  2018cites this paper
• Long-term Treatment with Low-Dose Caffeine Worsens BPSD-Like Profile in 3xTg-AD Mice Model of Alzheimer’s Disease and Affects Mice with Normal Aging

  2018cites this paper
• [Beyond Cognitive Impairment: Neuropsychiatric Symptoms in Neurodegenerative Dementias].

  2017cites this paper
• Antipsychotics, Antidepressants, Anticonvulsants, Melatonin, and Benzodiazepines for Behavioral and Psychological Symptoms of Dementia: a Systematic Review of Meta-analyses

  2017cites this paper
• Dextrometorphan-Paroxetine, But Not Dronabinol, Effective for Treatment-Resistant Aggression and Agitation in an Elderly Patient With Lewy Body Dementia.

  2017cites this paper
• Association between antipsychotics and adverse outcomes in dementia

  2017cites this paper